BG Medicine (BGMD) Reports In-Line Q3 EPS

Go back to BG Medicine (BGMD) Reports In-Line Q3 EPS

Ladenburg Thalmann Downgrades BG Medicine (BGMD) to Neutral

November 13, 2014 11:22 AM EST

Ladenburg Thalmann downgraded BG Medicine (NASDAQ: BGMD) from Buy to Neutral.

For an analyst ratings summary and ratings history on BG Medicine click here. For more ratings news on BG Medicine click here.

Shares of BG Medicine closed at $0.47 yesterday.

... More